These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 423685)
1. How does the FDA affect you and your practice? Novitch M Leg Aspects Med Pract; 1979 Mar; 7(3):23-6. PubMed ID: 423685 [No Abstract] [Full Text] [Related]
2. Use of drugs for unapproved indications: your legal responsibility. Eye Ear Nose Throat Mon; 1972 Dec; 51(12):493-5. PubMed ID: 4637969 [No Abstract] [Full Text] [Related]
3. Keeping prescription drugs safe and effective. Bryan PA Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343 [No Abstract] [Full Text] [Related]
4. Instrument of impediment. The regulatory monograph in medical communications. Archer J J Kans Med Soc; 1972 Aug; 73(8):385-8. PubMed ID: 5068010 [No Abstract] [Full Text] [Related]
5. Unapproved uses of approved drugs: The physician, the package insert, and the FDA. Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165 [No Abstract] [Full Text] [Related]
6. Federal drug laws and CRNAs. Blumenreich GA; Stallone DR; Tobin MH AANA J; 1990 Aug; 58(4):253-4. PubMed ID: 2399777 [No Abstract] [Full Text] [Related]
7. Relative efficacy. When the government decides what drug should be prescribed, is the patient better served? J Med Assoc State Ala; 1972 Sep; 42(3):200-12. PubMed ID: 5070864 [No Abstract] [Full Text] [Related]
8. Relative efficacy. When the government decides what drugs should be prescribed, is the patient better served? Ohio State Med J; 1972 Aug; 68(8):748-52 passim. PubMed ID: 5077306 [No Abstract] [Full Text] [Related]
9. Therapeutic freedom. Trout ME J Leg Med (N Y); 1974; 2(5):40-2. PubMed ID: 4548704 [No Abstract] [Full Text] [Related]
10. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526 [TBL] [Abstract][Full Text] [Related]
11. Attorney General's intrusion into clinical practice. Noah L N Engl J Med; 2002 Jun; 346(24):1918-9; author reply 1918-9. PubMed ID: 12066817 [No Abstract] [Full Text] [Related]
12. Editorial: The FDA reversed. Davis CE Va Med Mon (1918); 1974 Jan; 101(1):15-6. PubMed ID: 4809396 [No Abstract] [Full Text] [Related]
13. FDA in hot water again over cost of proposed drug labeling rule. Demkovich LE Natl J (Wash); 1979 Sep; 11(38):1568-70. PubMed ID: 10243426 [No Abstract] [Full Text] [Related]
14. Ten medical myths about FDA. Kennedy D West J Med; 1977 Dec; 127(6):529-34. PubMed ID: 595593 [No Abstract] [Full Text] [Related]
15. Sounding board. Creative tension: FDA and medicine. Kennedy D N Engl J Med; 1978 Apr; 298(15):846-50. PubMed ID: 345121 [No Abstract] [Full Text] [Related]
16. Risk management of marketed drugs: FDA and the interface with the practice of medicine. Uhl K; Honig P Pharmacoepidemiol Drug Saf; 2001 May; 10(3):205-8. PubMed ID: 11501332 [No Abstract] [Full Text] [Related]
17. The meaning of FDA approval. Fischer RG Pediatr Nurs; 1987; 13(5):360. PubMed ID: 3658520 [No Abstract] [Full Text] [Related]
18. FDA acts on estrogen, progestin labeling. FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006 [No Abstract] [Full Text] [Related]
20. Implications for the FDA/Center for Veterinary Medicine (CVM). Geyer RE J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592 [No Abstract] [Full Text] [Related] [Next] [New Search]